Drug manufacturers Xellia and Chartwell have notified 340B covered entities about possible refunds for overcharges. | Shutterstock

Two Drug Makers Providing Refunds for 340B Overcharges

In Federal, Pharma Industry, RegulatoryJune 2, 2021197 Views

Drug manufacturers Xellia Pharmaceuticals and Chartwell Rx have notified 340B covered entities about possible refunds for overcharges.

Xellia Pharmaceuticals

Drug manufacturers Xellia and Chartwell have notified 340B covered entities about possible refunds for overcharges.

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!